Day 5: Top Takeaways From ASCO26
Dr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia in myelofibrosis, advances in RAS-mutated mCRC, novel therapies for AML, and a potentially practice-changing trial in TNBC.
LINK TO FULL TRANSCRIPT
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.